Hearing aid training program may boost benefit for older adults — a trial puts it to the test

NCT ID NCT07719114

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial tests whether a structured aural rehabilitation program, called CSSAR, can improve hearing aid outcomes for new adult users aged 55 and older with mild-to-moderate hearing loss. Participants will either receive standard audiological care or standard care plus the CSSAR program, which includes a communication training session and a mobile auditory training app. The study measures changes in self-perceived hearing aid benefit, hearing handicap, and word recognition in noise over several follow-up visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a structured aural rehabilitation program called Clinically Streamlined and Structured Aural Rehabilitation (CSSAR)
What this could lead to
If it works, this could point toward a simple, clinic-friendly program that helps older adults get more benefit from their hearing aids.
What could go wrong
This is a small, early-stage trial with only 60 participants. The program may not provide meaningful improvement over standard care, and results may not apply to all hearing aid users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Case Western Reserve University

    Cleveland, Ohio, 44106, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.